Daniel Chong, MD
Hematology & Oncology · Fairfax, VANPI 1942462601
Payments from drug & device makers
Across 196 payments — averaging $1471.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$171K
- Genentech, Inc.$87K
- Seagen Inc.$21K
- Johnson & Johnson$5K
- Eli Lilly$2K
- AstraZeneca$501
- plus $2K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 20 | $170,652 |
| Genentech, Inc. | 14 | $86,656 |
| Seagen Inc. | 21 | $21,179 |
| Johnson & Johnson | 25 | $5,216 |
| Eli Lilly | 3 | $1,835 |
| AstraZeneca(2 entities) | 12 | $501 |
| Amgen | 11 | $244 |
| Gilead | 5 | $208 |
| Novartis | 8 | $190 |
| Daiichi Sankyo Inc. | 8 | $174 |
| Pfizer | 8 | $161 |
| AbbVie | 4 | $115 |
| Merck | 6 | $112 |
| GSK | 5 | $104 |
| Astellas Pharma US Inc | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| Rigel Pharmaceuticals, Inc. | 3 | $80 |
| Exelixis Inc. | 3 | $79 |
| Genentech USA, Inc. | 3 | $75 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Bristol Myers Squibb | 3 | $71 |
| Incyte Corporation | 2 | $48 |
| Array Biopharma Inc | 2 | $45 |
| Coherus Oncology, Inc. | 2 | $37 |
| Iovance Biotherapeutics, Inc. | 1 | $36 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $35 |
| Myriad Genetic Laboratories, Inc. | 1 | $34 |
| Organon | 2 | $33 |
| Genmab U.S., Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Eisai Inc. | 2 | $30 |
| Beigene USA, Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Mirati Therapeutics, Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$288,453 in reported general payments places this provider in the 80th percentile of 293 hematology & oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Fairfax
- Sekwon JangFairfax$11.8M
- Raymond WadlowFairfax$2.7M
- Mohamad SalkeniFairfax$2M
- Nicholas RobertFairfax$951K
- Timothy McCarthyFairfax$862K
- Dipti Patel-DonnellyFairfax$754K
- William ErshlerFairfax$485K
- Chao YinFairfax$428K
- Gregory OrloffFairfax$269K
- Craig PortellCharlottesville$12.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.